Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What happened to the guy on here that used to type in all caps and claimed to have owned 40+ mm shares with his wife? Hope he didn't sell.
So happy for you... And this isn't even the big bang yet ??
E-TRADE will let you do it as well and I think Ameritrade too.
Nice try. Sorry you didn't get in early lol
Passes all the checks to me:
https://www.investopedia.com/articles/active-trading/083115/4-signs-penny-stock-worth-millions.asp
Check the fundamentals:
Been around for a decade. Stopped financial reporting after bad investor/financing deals and lawsuits. Debts paid and are working to get current Summer 2018.
Industry Life-Cycle Analysis:
NOT a startup. Proven technology and science. Products on the market for years. Global Customer base.
Penny Stock Industries:
See above - fundamentals and life-cycle analysis.
Sound Management:
https://www.linkedin.com/in/mark-schena-27606364/
Enough Said.
Bottom Line: See DD document in Sticky
That's just in theory and hypothetical. Theranos never had actual PPS because their financials were all lies and overestimates. Arrayit's is based on real science and are working hard to get their financials in order. This is why I don't mind RRBB and ARYC taking time to put out the financial information - as long as it's accurate they are showing a commitment to being transparent with their shareholders
Theranos never made it to IPO. They were given a valuation of $9 billion at one point but silly Elizabeth Holmes wasn't even up to date with financials (because of the massive fraud) so they remained private and never sold a single share to the public (thankfully).
https://www.marketwatch.com/story/the-investors-duped-by-the-theranos-fraud-never-asked-for-one-important-thing-2018-03-19
I agree. I think that range is where this is headed
Exciting times, MikeCR! I recommend for anyone who hasn't read Bad Blood or at least a recap of how Theranos all went down, it will give such a great insight as to what Arrayit has going for them. Literally EVERYTHING Theranos has done to commit fraud based on its fake technology - Arrayit is doing it all legitimately with REAL products and science. From the CLIA certification, trials, prototypes, FDA, full disclosure - EVERYTHING Arrayit is doing is so opposite of what Theranos lied about. Knowing how much investors bought into their (Theranos) fraud hoping the science was real - they can finally be more optimistic about a company with a better reputation a decade in the making.
Ah yeah good point. I was thinking they meant retail pharma because I just read "Bad Blood" the Theranos story and it's really uncanny how similar Arrayit's goals are to everything Theranos wanted to do. They (Theranos) had deals in place with Walgreens and Safeway to have health centers in their retail locations so customers can have blood tested conveniently. I just imagined Arrayit trying to repair those broken relationships and pick up where Theranos shattered them terribly.
I think the "Pharmaceutical Giants" are more so CVS, Walgreens, and Rite Aid though. I work for Kaiser and we're more of a healthcare organization than a pharmaceutical giant. But yes - you're right in the fact that we (Kaiser) could potentially sell Arrayit's products in our pharmacies as well someday
That's either Walgreens, CVS, or Rite Aid - or hopefully all three someday!! $ARYC
Stop asking for PRs and worrying about PRs. Arrayit uses Twitter (and sometimes Instagram) to give updates and it's just as good as a regular PR. Here's an important PR you should check out:
https://www.sec.gov/news/press-release/2013-2013-51htm
Nothing yet - I tried checking our supplier chain to see if anything they manufactured has been added to the database but nothing so far. I think the FDA approval is key moving forward. I'll post whatever I can (without putting employment at risk of course lol) if I can connect with the right people who'd know about this
thank you kind sir
Hell yes! Good for you man! $1 would be insane but I'm dreaming of $4 and uplist to NASDAQ
Last filing was 2 weeks ago on July 2:
https://www.open-public-records.com/court/new_york-14932872.htm
Not sure about the details though. Maybe someone has access to the filings that can share insight?
I'm so excited! Even with deals that fall through - it doesn't invalidate the capabilities and science behind their technology and products. You're absolutely right - there are SO many potential business opportunities. I am just so bummed that those frivolous lawsuits (Taub etc) really sh*t on ARYC's business. I'm glad that Mark and Rene are still powering through and making very calculated decisions now. I know a lot of share holders are frustrated with this slow pace but I am confident that management will pull through and be successful in the end.
Damn. I think ARYC was bidding for this contract with the USDA.
3M Wins USDA Food Safety Testing Contract
Jul 13, 2018 | staff reporter
NEW YORK (GenomeWeb) – 3M announced this week that the US Department of Agriculture Food Safety and Inspection Service (USDA FSIS) has selected the 3M Molecular Detection System for food pathogen detection.
The 3M Molecular Detection System is based on a combination of technologies, including isothermal DNA amplification and bioluminescence detection. According to the company, the system can simultaneously accommodate individual pathogen-specific assays, allowing users to run up to 96 different tests concurrently to look for a range of organisms across a variety of food and environmental samples.
Under the terms of their contract, USDA FSIS will use 3M's system as its primary method for the detection of Salmonella, Listeria monocytogenes, and Escherichia coli O157 — including H7 — in food such as meat, poultry, and egg-related products, the company said.
Additional terms of the deal were not disclosed.
EDIT UPDATE:
Oh I forgot this is what jeopardized the deal with USDA:
Arrayit Asks Court to Dismiss Request Seeking to Block Issuance of Shares
Apr 29, 2015 | staff reporter
NEW YORK (GenomeWeb) – Arrayit this week responded to an investor lawsuit over the company's alleged failure to meet the terms of an agreement to settle earlier litigation, arguing that it is the plaintiffs in the case who have not lived up to their end of the deal.
Additionally, Arrayit said that a contract to develop food safety testing technology with the US Department of Agriculture is in jeopardy based on the actions of one of the plaintiffs in the case.
In a filing with the US District Court for the Southern District of New York, Arrayit has also asked the court to dismiss the investors' request for an injunction that would bar the company from issuing certain securities to a group of lenders.
The roots of the legal row extend back to August 2014, when Arrayit investor Reuben Taub sued Arrayit's management for "fraud and failure to properly disclose withholding and other tax liabilities of the company" as well as "misrepresentations concerning the development costs for, and company's ownership interest in, OvaDx," a microarray-based test for early stage ovarian cancer that Arrayit has been developing with Avant Diagnostics, which spun off from Arrayit in 2011.
A month later, Arrayit disclosed in a filing with the US Securities and Exchange Commission that the suit had been dismissed and that it had entered into a deal to provide a company called Array Molecular — owned by Taub and certain other Arrayit investors including Irwin Zalcberg — with intellectual property for use in developing a DNA microarray platform for detecting pathogens in food.
Notably, this arrangement also included a contract Arrayit had struck with the USDA to develop the food-testing technology. According to court filings, it also required Arrayit to double the number of shares that could be purchased through warrants held by Taub and Zalcberg and to provide Zalcberg with additional shares and warrants.
Earlier this year, Taub sued Arrayit and its management for allegedly failing to meet the terms of the settlement, neglecting to transfer any IP or technology to Array Molecular, and not providing any securities to Taub and Zalcberg.
Zalcberg later joined the suit as a plaintiff.
As part of that suit, Taub asked the court to prevent Arrayit from distributing securities to certain parties that loaned the firm money, arguing that the securities represented the only asset that could be used to satisfy judgment in the case.
This week, Arrayit and its management asked the court to reject the plaintiffs' request to prevent it from issuing securities, stating that "there are no restrictions in any agreement between the parties that prevent Arrayit from issuing shares to anyone."
The request, Arrayit added, is part of an attempt by the plaintiffs to "refashion" the initial settlement agreement to their advantage.
Further, Arrayit claims that its settlement with Taub called for Array Molecular to raise up to $2 million to fund development of the food safety testing technology, but that the plaintiffs "have yet to raise a single dollar of that obligation."
Arrayit said that it has been working on the technology, anticipating reimbursement from Array Molecular for its expenses, but without that money it was forced to borrow $630,000 from various third parties. These loans included options for repayment in the form of Arrayit stock.
"Had [the] plaintiffs provided funding for the project, as agreed to, the loans would not have been necessary in the first place," Arrayit said. Although a portion of those loans have been converted to shares, additional conversion can be prevented by the plaintiffs, it added.
In a statement to the court, Arrayit CEO Rene Schena also claimed that its USDA contract has been threatened by Taub's actions at a scientific meeting last year.
Specifically, Arrayit alleged that Taub was present at the meeting, which included a presentation by the company and USDA collaborators, but that he was "so disruptive and insulting to the USDA representative in charge of developing the [food safety] test that she checked further into Taub's background," discovering that he had pleaded no contest to securities violations charges by the SEC in 1999.
Schena stated in the court filing that the USDA representative told her that the agency "would not move forward" with the food safety project as long as Taub was involved.
Arrayit has asked the court to reject any injunction request that would prevent it from issuing stock to its lenders, or, if an injunction is granted, to require the plaintiffs to post a $2 million bond to pay off the lenders.
Requests for comment from Taub and Arrayit were not returned.
I think there's still some legal issues with OvaDX so I'm not expecting them to have any progress on it quite soon. There's probably more chance of the USDA food safety test being FDA approved:
Arrayit Signs CRADA with USDA to Develop Food Safety Technology
Dec 11, 2014 | staff reporter
NEW YORK (GenomeWeb) – Arrayit announced on Wednesday that it has entered into a cooperative research and development agreement with the US Department of Agriculture to develop technology to rapidly detect foodborne pathogens.
https://www.sec.gov/Archives/edgar/data/1084507/000135448815001753/aryc_10k.htm
The collaboration will combine Arrayit's DNA microarray platform with the USDA's patent pending method of detecting DNA sequences of pathogens in food. Under the agreement, the Sunnyvale, Calif.-based firm will work with the USDA's Agricultural Research Service to develop and validate a rapid, portable, high-throughput detection system for the surveillance of bacterial and viral pathogens, including Hepatitis, Escherichia coli, Salmonella, Listeria, Campylobacter and Norovirus.
Nov 2015:
Arrayit USDA and FDA Food Safety Microarray Tests can detect E. coli implicated at Chipotle
May 23:
Arrayit-USDA food safety testing team receives publication invitation from the top scientific journal SPG Open published by Science Publishing Group headquartered in Zurich Switzerland USA and featuring leading interdisciplinary scientific publications.
July 2:
Arrayit USDA food safety testing team recommends routine "farm to fork" pathogen testing to ensure the safety of the nation's food supply by rapidly and affordably detecting pathogenic E. coli implicated in the recent outbreak impacting romaine lettuce
July 11:
Arrayit USDA food safety test readily detects the E coli pathogen implicated in the recent incident in Gatlinburg Tennessee. Our CLIA clinical team strongly recommends routine testing on cruise ships, amusements parks and other fresh water sporting venues
Agreed - they have a long relationship with DOCRO and I believe they should* have been able to move forward in the past with other ventures if had it not been for the silly lawsuits taking place during that time. I think they are in a much better place now so I hope DOCRO will be able to assist
For those who want to watch it on 7/28, find your FOX Business Channel here:
https://www.foxbusiness.com/channel-finder
It should look like an informercial and in case you miss it you'll probably find it here:
http://talkbusiness360.com/recent-episodes/
Exactly. They wouldn't be setting up mega deals with the USDA, Albertson's, and Kaiser Permanente if they weren't 100% confident in their products
AWESOME! Welcome aboard!!! $$$ARYC
Tell me about it! Can't wait till we approach the financial release(s) and FDA approvals. I'm not expecting much from the first batch of re-done financials (2014-2015?) but the ones after 2016 moving forward are going to hopefully be positive. Exciting times for us shareholders!!!
God I really wish I could provide insight on this Ace, but I think it will resume progress after FDA clearance. Huge things coming IMO
Probably won't matter since it might be double this in a couple of weeks anyways. That FDA approval has so many implications for future business. I just can't wait for it to all start coming together. The combination of getting CLIA certified for Medicare/Medicaid and FDA approvals and getting current with financials is going to push this PPS beyond what I ever expected. NASDAQ uplisting won't be a pipe dream anymore once they get current with the SEC
cool! Thanks for bumping up the PPS! Cheer$ to you!
God I really hope so. I want to buy my mom a good birthday present and my daughter tickets to Hamilton and help someone out who just got laid off work.
Good question. I'm hoping anyone with L2 access can give us more insight. I'm just hoping for the best - been here for 2 years. Bought a small amount at 0.0073 so I'm happy to be almost 10x growth.
and yet here we are in the green. Give it a break
I don't. It was their decision to either bash the stock or not buy in when it was low. I feel good for everyone who bought in and are holding on until all the DD pays off.
Sure if he wanted to - but he'll probably be creating teaching videos from his yacht if he still loves teaching :)
I wonder if ARYC management will be attending this event in 3 days:
Arrayit senior management invited to the prestigious and exclusive invitation-only New York Private Equity Forum at the Yale Club in New York City July 12 2018 featuring breakthrough technology, money managers and ultra-high-end public company networking EquityForum
Excellent point
I think as everything comes together with financials, FDA, USDA, deals with retailers, deals with pharmacies, deals with healthcare orgs - it will bring exposure to the larger companies. I know that this is a family-owned operation and has been for years but I do hope that when the opportunity comes, the owners will consider buyout offers from the likes of Illumina or one of its competitors:
https://www.nasdaq.com/symbol/ilmn/competitors
Thanks. H through Z are what we're waiting for though.
Looks like resistance at .0509 then next barrier at .0538
https://www.barchart.com/stocks/quotes/ARYC/cheat-sheet
Will churn around this area at .05+ for a while until financials are released or updated news from FDA and USDA. Wish I knew what the timeline is for FDA approvals
Looks like strong support around the .0450s. I'm not worried at all. It's going to trade at this level until official news comes. I'm in it for the long haul and Ronco Rotisserie this baby - set it and forget it.
Absolutely! Having the MD approval definitely validates the test. After reading the Theranos book - I'm so glad that Arrayit and Dr. Mark Schaena is doing EVERYTHING the opposite of what Elizabeth Holmes did. I know a lot of people disregard all the tweets but I'm glad they are disclosing how much business they are doing. All we need now are all the financials.